LOGICBIO THERAPEUTICS INC - COM (LOGC)

CUSIP: 54142F102

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COM
Total 13F shares
17,395,310
Share change
+6,653,854
Total reported value
$132,729,192
Price per share
$7.63
Number of holders
54
Value change
+$50,673,431
Number of buys
35
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 54142F102?
CUSIP 54142F102 identifies LOGC - LOGICBIO THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LOGICBIO THERAPEUTICS INC - COM (LOGC) as of Q4 2020

As of 31 Dec 2020, LOGICBIO THERAPEUTICS INC - COM (LOGC) was held by 54 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,395,310 shares. The largest 10 holders included ORBIMED ADVISORS LLC, FRANKLIN RESOURCES INC, SAMLYN CAPITAL, LLC, BlackRock Inc., VANGUARD GROUP INC, EcoR1 Capital, LLC, FMR LLC, Lion Point Capital, LP, BAKER BROS. ADVISORS LP, and JPMORGAN CHASE & CO. This page lists 54 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.